Times Square Capital Management, LLC Bio Techne Corp Transaction History

Times Square Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $40.5 Million - $56.1 Million	-275,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $34.5 Million - $39.4 Million	-237,865 Reduced 46.38%	275,000 $40.7 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $21.7 Million - $24.9 Million	164,865 Added 47.38%	512,865 $77.5 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $42.2 Million - $46.9 Million	348,000	348,000 $45.1 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.